【结 构 式】 |
【分子编号】40806 【品名】6,7-dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one 【CA登记号】 |
【 分 子 式 】C6H6N4O 【 分 子 量 】150.14 【元素组成】C 48% H 4.03% N 37.32% O 10.66% |
合成路线1
该中间体在本合成路线中的序号:(X)4-Methyl-5-nitroimidazole (I) is condensed with benzaldehyde (II) in the presence of piperidine to produce the 4-styryl imidazole (III). Alkylation of imidazole (III) with benzyl chloride leads to a 3:1 mixture of regioisomeric N-benzyl imidazoles (IV) and (V). Ozonolysis of this mixture, followed by oxidative work-up of the ozonide with performic acid, allows isolation of the desired imidazolecarboxylic acid (VI) by employing a differential precipitation technique. Activation of acid (VI) with CDI, and further treatment of the resultant imidazolide with potassium methanenitronate gives rise to nitro ketone (VII). Both nitro groups of (VII) are then reduced by SnCl2 in concentrated HCl to furnish diamine (VIII). Then, removal of the N-benzyl group of (VIII) by catalytic hydrogenation over Pd/C yields imidazole (IX). Ring closure of (IX) in the presence of triethyl orthoformate produces the imidazodiazepinone (X)
【1】 Chan, E.; et al.; Total synthesis of (8R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol (pentostatin), the potent inhibitor of adenosine deaminase. J Org Chem 1982, 47, 18, 3457. |
【2】 Baker, D.C.; Putt, S.R.; A total synthesis of pentostatin, the potent inhibitor of adenosine deaminase. J Am Chem Soc 1979, 101, 20, 6127. |
【3】 Baker, D.C.; Putt, S.R. (Pfizer Inc.); 2-Amino-1-(5-amino-1H-imidazol-4-yl)ethanone and method of preparation. DE 2835144; ES 472478; ES 479618; GB 2005661; GB 2013680; US 4117229 . |
【4】 Baker, D.C.; Putt, S.R. (Pfizer Inc.); Imidazole cpds., methods for their production and conversion of said cpds. into (R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazol[4,5-d][1,3]diazepin-8-ol. US 4195176 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 62513 | 4-methyl-5-nitro-1H-imidazole | C4H5N3O2 | 详情 | 详情 | |
(II) | 10498 | Benzaldehyde;Benzoic aldehyde;Phenylmethanal | 100-52-7 | C7H6O | 详情 | 详情 |
(III) | 62514 | 5-nitro-4-[(E)-2-phenylethenyl]-1H-imidazole | C11H9N3O2 | 详情 | 详情 | |
(IV) | 62515 | 1-benzyl-4-nitro-5-[(E)-2-phenylethenyl]-1H-imidazole | C18H15N3O2 | 详情 | 详情 | |
(V) | 62516 | 1-benzyl-5-nitro-4-[(E)-2-phenylethenyl]-1H-imidazole | C18H15N3O2 | 详情 | 详情 | |
(VI) | 62517 | 1-benzyl-4-nitro-1H-imidazole-5-carboxylic acid | C11H9N3O4 | 详情 | 详情 | |
(VII) | 62518 | 1-(1-benzyl-4-nitro-1H-imidazol-5-yl)-2-nitro-1-ethanone | C12H10N4O5 | 详情 | 详情 | |
(VIII) | 62519 | 2-amino-1-(4-amino-1-benzyl-1H-imidazol-5-yl)-1-ethanone | C12H14N4O | 详情 | 详情 | |
(IX) | 62520 | 2-amino-1-(5-amino-1H-imidazol-4-yl)-1-ethanone | C5H8N4O | 详情 | 详情 | |
(X) | 40806 | 6,7-dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one | C6H6N4O | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(X)After silylation of the imidazodiazepinone (X) employing bis(trimethylsilyl)trifluoroacetamide, glycosylation with 2-deoxy-3,5-di-p-toluoyl-D-erythro-pentofuranosyl chloride (XI) leads to a mixture of glycoside anomers (XII) and (XIII), from which the desired beta-anomer (XII) can be isolated by either column chromatography or by fractional crystallization. The toluoyl ester groups of (XII) are then removed by methanolysis in the presence of NaOMe to afford (XIV). Finally, reduction of ketone (XIV) gives rise to a 60:40 mixture of the target (R)-hydroxy imidazodiazepine along with its (S)-epimer (XV), which are separated by reverse-phase preparative HPLC
【1】 Baker, D.C.; Putt, S.R.; A total synthesis of pentostatin, the potent inhibitor of adenosine deaminase. J Am Chem Soc 1979, 101, 20, 6127. |
【2】 Chan, E.; et al.; Total synthesis of (8R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol (pentostatin), the potent inhibitor of adenosine deaminase. J Org Chem 1982, 47, 18, 3457. |
【3】 Baker, D.C.; Putt, S.R. (Pfizer Inc.); Imidazole cpds., methods for their production and conversion of said cpds. into (R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazol[4,5-d][1,3]diazepin-8-ol. US 4195176 . |
【4】 Baker, D.C.; Putt, S.R. (Pfizer Inc.); 2-Amino-1-(5-amino-1H-imidazol-4-yl)ethanone and method of preparation. DE 2835144; ES 472478; ES 479618; GB 2005661; GB 2013680; US 4117229 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(X) | 40806 | 6,7-dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one | C6H6N4O | 详情 | 详情 | |
(XI) | 37194 | (2R,3S)-5-Chloro-2-[[(4-methylbenzoyl)oxy]methyl]tetrahydro-3-furanyl 4-methylbenzoate | 4330-21-6 | C21H21ClO5 | 详情 | 详情 |
(XII) | 62522 | {(2R,3S,5R)-3-[(4-methylbenzoyl)oxy]-5-[8-oxo-7,8-dihydroimidazo[4,5-d][1,3]diazepin-3(6H)-yl]tetrahydro-2-furanyl}methyl 4-methylbenzoate | C27H26N4O6 | 详情 | 详情 | |
(XIII) | 62521 | {(2R,3S,5S)-3-[(4-methylbenzoyl)oxy]-5-[8-oxo-7,8-dihydroimidazo[4,5-d][1,3]diazepin-3(6H)-yl]tetrahydro-2-furanyl}methyl 4-methylbenzoate | C27H26N4O6 | 详情 | 详情 | |
(XIV) | 62523 | 3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-6,7-dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one | C11H14N4O4 | 详情 | 详情 | |
(XV) | 62524 | (8S)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol | C11H16N4O4 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(VI)Dibenzyl malonate (I) was alkylated with 3-(trifluoromethyl)benzyl bromide (II) in the presence of Na in DMF to yield the 3-(trifluoromethyl)benzylmalonate (III). Further alkylation of (III) with 1,4-dibromobutane (IV) provided the bromobutyl derivative (V). Condensation of the known 6,7-dihydroimidazo[4,5-d][1,3]diazepin-8-one (VI) with bromide (V) in the presence of NaH and NaI furnished adduct (VII). The keto group of (VII) was then reduced to alcohol (VIII) employing NaBH4 in MeOH-CH2Cl2. Finally, hydrogenolysis of the benzyl ester groups of (VIII) in the presence of Pd/C and Et3N afforded the title dicarboxylate triethylammonium salt.
【1】 Bookser, B.C.; Kasibhatla, S.R.; Erion, M.D.; AMP deaminase inhibitors. 4. Further N3-substituted coformycin aglycon analogues: N3-alkylmalonates as ribose 5'-monophosphate mimetics. J Med Chem 2000, 43, 8, 1519. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 16013 | dibenzyl malonate | 15014-25-2 | C17H16O4 | 详情 | 详情 |
(II) | 40803 | 1-(bromomethyl)-3-(trifluoromethyl)benzene | 402-23-3 | C8H6BrF3 | 详情 | 详情 |
(III) | 40804 | dibenzyl 2-[3-(trifluoromethyl)benzyl]malonate | C25H21F3O4 | 详情 | 详情 | |
(IV) | 11883 | 1,4-Dibromobutane; 1,4-Butylene bromide | 110-52-1 | C4H8Br2 | 详情 | 详情 |
(V) | 40805 | dibenzyl 2-(4-bromobutyl)-2-[3-(trifluoromethyl)benzyl]malonate | C29H28BrF3O4 | 详情 | 详情 | |
(VI) | 40806 | 6,7-dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one | C6H6N4O | 详情 | 详情 | |
(VII) | 40807 | dibenzyl 2-[4-[8-oxo-7,8-dihydroimidazo[4,5-d][1,3]diazepin-3(6H)-yl]butyl]-2-[3-(trifluoromethyl)benzyl]malonate | C35H33F3N4O5 | 详情 | 详情 | |
(VIII) | 40808 | dibenzyl 2-[4-[8-hydroxy-7,8-dihydroimidazo[4,5-d][1,3]diazepin-3(6H)-yl]butyl]-2-[3-(trifluoromethyl)benzyl]malonate | C35H35F3N4O5 | 详情 | 详情 |